CD5 (CD5 molecule)

2007-02-01  

Identity

HGNC
LOCATION
11q12.2
LOCUSID
ALIAS
LEU1,T1
FUSION GENES

Other Information

Locus ID:

NCBI: 921
MIM: 153340
HGNC: 1685
Ensembl: ENSG00000110448

Variants:

dbSNP: 921
ClinVar: 921
TCGA: ENSG00000110448
COSMIC: CD5

RNA/Proteins

Gene IDTranscript IDUniprot
ENSG00000110448ENST00000347785P06127
ENSG00000110448ENST00000544014F5GYK3

Expression (GTEx)

0
5
10
15
20

Pathways

PathwaySourceExternal ID
Hematopoietic cell lineageKEGGko04640
Hematopoietic cell lineageKEGGhsa04640

Protein levels (Protein atlas)

Not detected
Low
Medium
High

References

Pubmed IDYearTitleCitations
379533732024Expression of CD5 in salivary gland tumors: an ancillary marker for carcinoma showing thymus-like differentiation (CASTLE) of the major salivary gland.0
379533732024Expression of CD5 in salivary gland tumors: an ancillary marker for carcinoma showing thymus-like differentiation (CASTLE) of the major salivary gland.0
372309722023CD5: from antiquated T cell marker to immunotherapy's new hope.1
372309722023CD5: from antiquated T cell marker to immunotherapy's new hope.1
353321322022T cells expressing CD5/CD7 bispecific chimeric antigen receptors with fully human heavy-chain-only domains mitigate tumor antigen escape.24
357673662022Gene variation impact on prostate cancer progression: Lymphocyte modulator, activation, and cell adhesion gene variant contribution.2
360022322022CD5 Suppresses IL-15-Induced Proliferation of Human Memory CD8(+) T Cells by Inhibiting mTOR Pathways.3
353321322022T cells expressing CD5/CD7 bispecific chimeric antigen receptors with fully human heavy-chain-only domains mitigate tumor antigen escape.24
357673662022Gene variation impact on prostate cancer progression: Lymphocyte modulator, activation, and cell adhesion gene variant contribution.2
360022322022CD5 Suppresses IL-15-Induced Proliferation of Human Memory CD8(+) T Cells by Inhibiting mTOR Pathways.3
32896973202114-Color single tube for flow cytometric characterization of CD5+ B-LPDs and high sensitivity automated minimal residual disease quantitation of CLL/SLL.4
333140172021Clinical and biological features of B-cell neoplasms with CDK6 translocations: an association with a subgroup of splenic marginal zone lymphomas displaying frequent CD5 expression, prolymphocytic cells, and TP53 abnormalities.3
340701592021Contribution of Evolutionary Selected Immune Gene Polymorphism to Immune-Related Disorders: The Case of Lymphocyte Scavenger Receptors CD5 and CD6.5
32896973202114-Color single tube for flow cytometric characterization of CD5+ B-LPDs and high sensitivity automated minimal residual disease quantitation of CLL/SLL.4
333140172021Clinical and biological features of B-cell neoplasms with CDK6 translocations: an association with a subgroup of splenic marginal zone lymphomas displaying frequent CD5 expression, prolymphocytic cells, and TP53 abnormalities.3

Citation

Dessen P

CD5 (CD5 molecule)

Atlas Genet Cytogenet Oncol Haematol. 2007-02-01

Online version: http://atlasgeneticsoncology.org/gene/46449